Department of Pharmacy, UW Health, Madison, Wisconsin,
Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
WMJ. 2024 Sep;123(4):272-277.
Probiotics are synthetic oral supplements containing live bacterial and fungal species hypothesized to help with various gastrointestinal conditions. However, they can cause infection if the organism spreads outside of the gastrointestinal tract. The aim of this study was to identify and describe patients who experienced systemic infections caused by probiotic use.
This study was a retrospective chart review of pediatric and adult patients at academic medical centers who received probiotics and subsequently developed positive cultures from a sterile site for probiotic-related species. Two individuals completed the chart reviews to determine if the probiotic was the true cause of the infection.
, , and cultures were reviewed, with a total of 71, 8, and 2 cultures isolated from sterile sites for each organism, respectively. Further review revealed 23 cultures from 13 unique patients who were taking -containing probiotics. Four patients without gastrointestinal tract compromise were included in the final analysis, including 1 patient whose culture was confirmed as identical to the probiotic. Types of infections included meningitis and bacteremia. Targeted antimicrobial therapy included ampicillin, ampicillin-sulbactam, and piperacillin-tazobactam, with total durations of therapy ranging from 10 to 22 days. No patients had mortality attributed to infection.
Probiotics are not harmless supplements as they come with risk of serious infection as demonstrated in this review. Before use, the risks of probiotics should be considered carefully for each individual patient. Clinicians should consider avoiding probiotics in hospitalized patients, especially those with vascular or extra-ventricular access devices.
益生菌是一种含有活细菌和真菌的合成口服补充剂,据推测有助于治疗各种胃肠道疾病。然而,如果这些生物体在胃肠道以外的部位扩散,它们可能会引起感染。本研究的目的是确定和描述因使用益生菌而发生全身感染的患者。
这是一项对学术医疗中心的儿科和成人患者进行的回顾性图表审查,这些患者在接受益生菌治疗后,从无菌部位获得了与益生菌相关的阳性培养物。有两名研究人员完成了图表审查,以确定益生菌是否是感染的真正原因。
共审查了 、 和 株培养物,分别从无菌部位分离出 71 株、8 株和 2 株与每种生物体相关的培养物。进一步审查显示,有 23 株培养物来自 13 名接受含 益生菌的独特患者。最终分析包括 4 名无胃肠道损害的患者,其中 1 名患者的培养物被确认为与益生菌完全一致。感染类型包括脑膜炎和菌血症。针对性的抗菌治疗包括氨苄西林、氨苄西林-舒巴坦和哌拉西林-他唑巴坦,治疗总持续时间从 10 天到 22 天不等。没有患者因 感染而死亡。
正如本综述所示,益生菌并不是无害的补充剂,它们存在严重感染的风险。在使用之前,应根据每个患者的具体情况仔细考虑益生菌的风险。临床医生应考虑避免在住院患者中使用益生菌,尤其是那些有血管或脑室外接入装置的患者。